Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Drug Resistance

Free Subscription 26.01.2026 2 Infect Control Hosp Epidemiol 1 Int J Antimicrob Agents 21 J Antimicrob Chemother 8 J Infect Dis 1 J Virol 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Infect Control Hosp Epidemiol

1. WONG SC, Lam GK, Singh RD, Chiu EK, et al
   Bridging borders: adapting the Orange County methicillin-resistant Staphylococcus aureus decolonization protocol for an infirmary unit in Hong Kong.
   Infect Control Hosp Epidemiol. 2026 Jan 23:1-8. doi: 10.1017/ice.2025.10388.
   PubMed         Abstract available
   
   
2. FLORES EA, Singh R, McKinnell JA, Tjoa TT, et al
   Impact of routine chlorhexidine bathing and nasal iodophor on MDRO colonization and environmental contamination in nursing homes.
   Infect Control Hosp Epidemiol. 2025;46:896-902.
   PubMed         Abstract available
   
   

   
   Int J Antimicrob Agents

3. BIANCO G, Biffignandi GB, Boattini M, Comini S, et al
   Resistance to sulbactam/durlobactam in carbapenem-resistant Acinetobacter baumannii in treatment-naive setting: in vitro data and genomic insights from Italian bloodstream isolates.
   Int J Antimicrob Agents. 2026 Jan 16:107718.
   PubMed         Abstract available
   
   

   
   J Antimicrob Chemother

4. ZHANG X, Xie Y, Liu F, Cheng Z, et al
   Simulated lung exposure in pneumonia patients to evaluate the antibacterial capacity and resistance suppression of clinical tigecycline regimens against carbapenem-resistant Acinetobacter baumannii.
   J Antimicrob Chemother. 2026;81:dkaf477.
   PubMed         Abstract available
   
   
5. ZHU Z, Hua X, Ke Y
   Azithromycin resistance in non-typhoidal Salmonella: a review.
   J Antimicrob Chemother. 2026;81:dkaf341.
   PubMed         Abstract available
   
   
6. ZHANG Y, Zhang X, Han S, Wang D, et al
   Progress in the study of drug resistance mechanism of Bacillus cereus.
   J Antimicrob Chemother. 2026;81:dkaf399.
   PubMed         Abstract available
   
   
7. PALICH R, Ghosn J, Lacombe K, Palacios C, et al
   Switching from etravirine to doravirine in virologically suppressed people with HIV: results from the French multicentre SWEED observational study.
   J Antimicrob Chemother. 2026;81:dkaf410.
   PubMed         Abstract available
   
   
8. ANDERSSON M, Zimmermann N, Kloft C, Aulin LBS, et al
   Antibiotic pharmacodynamics: from MIC to advanced metrics and their applications.
   J Antimicrob Chemother. 2026;81:dkaf374.
   PubMed         Abstract available
   
   
9. ALMEIDA-SANTOS AC, Tedim AP, Duarte B, Silva LM, et al
   Unnoticed spread of linear VanA-plasmids in vancomycin-variable Enterococcus faecium strains across different regions: a diagnostics challenge.
   J Antimicrob Chemother. 2025 Nov 20:dkaf409. doi: 10.1093.
   PubMed         Abstract available
   
   
10. VERMA S, Tilak R, Singh G, Singh S, et al
    Multicentre investigation of Wickerhamomyces anomalus fungemia in India: emerging resistance and mechanistic insights.
    J Antimicrob Chemother. 2026;81:dkaf420.
    PubMed         Abstract available
    
    
11. MOSTAFA R, Mohammed S, Ahmed AS, Aly SA, et al
    Nanoparticle-based co-delivery of ciprofloxacin and meropenem enhances synergistic activity against multidrug-resistant hypervirulent Klebsiella pneumoniae clinical isolates.
    J Antimicrob Chemother. 2026;81:dkaf422.
    PubMed         Abstract available
    
    
12. SHAW D, Thakur S, Ghosh A, Dogra S, et al
    Efflux-mediated multidrug resistance mechanism in Trichophyton indotineae and Trichophyton rubrum; role of ABC transporters and MFS gene.
    J Antimicrob Chemother. 2026;81:dkaf434.
    PubMed         Abstract available
    
    
13. SOULIE C, Agher R, Fauchois A, Abdi B, et al
    Despite increasing use of integrase inhibitors to treat HIV infection, resistance to this class remains stable.
    J Antimicrob Chemother. 2026;81:dkaf454.
    PubMed         Abstract available
    
    
14. COLE MJ, Doumith M, Vickers A, Alexander S, et al
    In vitro activity of gepotidacin against a challenging panel of multidrug-resistant Neisseria gonorrhoeae isolates.
    J Antimicrob Chemother. 2026;81:dkag001.
    PubMed         Abstract available
    
    
15. CHEN GJ, Lee NY, Tsai MS, Huang SH, et al
    Resistance to second-generation integrase inhibitors in people with HIV following treatment failure on dolutegravir- or bictegravir-based ART in Taiwan.
    J Antimicrob Chemother. 2026;81:dkaf488.
    PubMed         Abstract available
    
    
16. SWEENEY EL, Tickner JA, Ertl NG, Bauer MJ, et al
    Rapid molecular diagnostics for detection of extensively drug-resistant Salmonella Typhi.
    J Antimicrob Chemother. 2026;81:dkaf481.
    PubMed         Abstract available
    
    
17. WU M, Li J, Zhou Z, Chen Y, et al
    Research progress on resistance mechanisms and clinical efficacy of tigecycline against Klebsiella pneumoniae.
    J Antimicrob Chemother. 2026;81:dkaf504.
    PubMed         Abstract available
    
    
18. STURM PDJ, Van Niekerk JM, Lestrade PPA, Peters CJA, et al
    Prevalence of macrolide resistance in Mycoplasma pneumoniae in The Netherlands.
    J Antimicrob Chemother. 2026;81:dkaf475.
    PubMed         Abstract available
    
    
19. DWIBEDY SK, Padhy I, Mohapatra SS
    A comprehensive analysis of the mutational landscape determining polymyxin resistance in Klebsiella pneumoniae.
    J Antimicrob Chemother. 2026;81:dkaf503.
    PubMed         Abstract available
    
    
20. ZHUO J, Xu J, Chi Y, Zhang N, et al
    Ceftazidime/avibactam: a potent arsenal against multidrug-resistant Pseudomonas aeruginosa-unveiling in vitro and in vivo strategies.
    J Antimicrob Chemother. 2026;81:dkaf495.
    PubMed         Abstract available
    
    
21. MIELKO-NIZIALEK KA, Jablonski S, Wisniewski J, Milczewska J, et al
    Antibiotic resistance of Pseudomonas aeruginosa strains-intracellular metabolomics analysis.
    J Antimicrob Chemother. 2026;81:dkaf453.
    PubMed         Abstract available
    
    
22. SAAD BAA, Volpe-Chaves CE, de Oliveira CTF, Conte BS, et al
    The emerging clinical relevance and antimicrobial resistance of Pluralibacter gergoviae: a systematic review.
    J Antimicrob Chemother. 2026;81:dkaf476.
    PubMed         Abstract available
    
    
23. TASCINI C, Bianco G, Bonomo RA, Gaibani P, et al
    In vitro activity of cefepime/zidebactam against sulbactam/durlobactam-susceptible and -resistant Acinetobacter baumannii clinical isolates.
    J Antimicrob Chemother. 2026;81:dkaf467.
    PubMed         Abstract available
    
    
24. MCCRACKEN M, Lerminiaux N, Adam HJ, Baxter M, et al
    Enterococcus faecium harbouring vanA, optrA and cfr(D) on a linear plasmid in Canada: a CANWARD surveillance case.
    J Antimicrob Chemother. 2026;81:dkaf478.
    PubMed         Abstract available
    
    

    
    J Infect Dis

25. SELZER L, Demirdjian S, Falkard B, Li J, et al
    Resistance Analysis of Low-Level Virologic Rebound During HIV-1 Treatment with Lenacapavir and Broadly Neutralizing Antibodies Teropavimab and Zinlirvimab.
    J Infect Dis. 2025 Nov 5:jiaf559. doi: 10.1093.
    PubMed         Abstract available
    
    
26. COX S, Andreatta K, Hendricks MR, Li J, et al
    Resistance Analyses of Lenacapavir, Emtricitabine/Tenofovir Alafenamide and Emtricitabine/Tenofovir Disoproxil Fumarate in the PURPOSE 1 and 2 Studies.
    J Infect Dis. 2025 Oct 24:jiaf533. doi: 10.1093.
    PubMed         Abstract available
    
    
27. MC GANN P, Luo TL, Martin MJ, Dao HD, et al
    Foreign Combatants Wounded in Ukraine Colonized by Extensively Drug-Resistant Organisms: A Potential Source of Global Dissemination.
    J Infect Dis. 2026;233:e183-e191.
    PubMed         Abstract available
    
    
28. KASAI M, Nakano S, Koide S, Otake S, et al
    Prevalence of candidate vaccine targets and genomic features of pediatric invasive Streptococcus agalactiae in Japan.
    J Infect Dis. 2025 Oct 9:jiaf491. doi: 10.1093.
    PubMed         Abstract available
    
    
29. KUSTER S, Gottlich C, O'Shea T, Ghert M, et al
    The Burden of Surgical Site Infections With Pathogens Presumably Resistant to Perioperative Prophylaxis in Orthopedic Tumor Surgery: Secondary Analysis of the Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY) Trial.
    J Infect Dis. 2026;233:e174-e182.
    PubMed         Abstract available
    
    
30. KELLY C, Lester JS, Bradshaw D, Bibby DF, et al
    Real-world prevalence of non-integrase INSTI resistance-associated mutations and virological outcomes in people who have recently acquired HIV-1 in the UK.
    J Infect Dis. 2025 Sep 26:jiaf500. doi: 10.1093.
    PubMed         Abstract available
    
    
31. HURST JR, Addo M, Li A, Khera SS, et al
    Monkeypox Virus Shedding Despite Tecovirimat Treatment in a Cohort in Toronto, Canada.
    J Infect Dis. 2026;233:e132-e139.
    PubMed         Abstract available
    
    
32. VO-QUANG E, Rodriguez C, Ly A, Ndow G, et al
    Virological tools fail to properly identify "unusual" hepatitis C virus subtypes resistant to direct-acting antiviral drugs in The Gambia.
    J Infect Dis. 2025 Jul 22:jiaf378. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Virol

33. YANG Q, Xue B, Qiu X, Yang K, et al
    Molecular mechanism of resistance to lonafarnib conferred by mutations in the cysteine-rich region of respiratory syncytial virus fusion glycoprotein and discovery of a lonafarnib-derived antiviral PROTAC.
    J Virol. 2026;100:e0148725.
    PubMed         Abstract available
    
    

    
    PLoS One

34. HAILEMICHAEL EB, Desta AF, Taye G, Gari SR, et al
    Prevalence, microbiological profiles, and determinants of hospital-acquired pneumonia in Addis Ababa: A focus on Pseudomonas aeruginosa and its antimicrobial resistance patterns in three hospitals.
    PLoS One. 2026;21:e0340680.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum